Acta Neurochirurgica

, 150:663 | Cite as

Administration off label of recombinant factor-VIIa (rFVIIa) to patients with blunt or penetrating brain injury without coagulopathy

  • M. Zaaroor
  • J. F. Soustiel
  • B. Brenner
  • Y. Bar-Lavie
  • U. Martinowitz
  • L. Levi
Clinical Article

Summary

Traumatic brain contusions may increase in size over time or may develop at a delay after injury. This may lead to neurological deterioration, long term morbidity or even death. Coagulation disorders after injury can contribute to progression of haemorrhage. Recombinant activated factor VII (rFVIIa) was used in 12 patients with a severe head injury who had no systemic coagulopathy but who were considered to be at risk of progression of their intracranial lesion. Twelve consecutive patients suffering from life-threatening acute head injuries from blunt (3 cases) and penetrating mechanisms were given with rFVIIa, either to prevent the expected development of brain contusion or to assist in bleeding control during surgery. In 11 patients, rFVIIa was given by the attending neurosurgeon. Two of the patients died of their severe penetrating injuries one of whom had severe vasospasm 2 days after administration of rFVIIa. The other 11 patients did not appear to suffer any treatment-related adverse effects. When the drug was given prophylactically to prevent brain resection (6 cases) or to limit the need for widening resection (5 cases), marked control was achieved in seven cases, and a lesser effect was observed in the other 4 cases. We conclude that, in a small and highly individually selected series of patients with severe head injury, the administration of rFVIIa did not lead to adverse effects. Although the majority of patients were considered to be at high risk of progression of their lesions, this occurred in only one. The early use of rFVIIa in head injured patients without systemic coagulopathy may reduce the occurrence of enlargement of contusions, the requirement of further operation, and adverse outcome. Prospective randomised controlled studies are required to investigate this.

Keywords: Brain contusion; brain injury-penetrating; recombinant factor-VIIa. 

References

  1. Brandvold, B, Levi, L, Feinsod, M, George, ED 1990Penetrating craniocerebral injuries in the Israeli involvement in the Lebanese conflict, 1982–1985. Analysis of a less aggressive surgical approachJ Neurosurg721521PubMedGoogle Scholar
  2. Chang, EF, Meeker, M, Holland, MC 2006Acute traumatic intraparenchymal hemorrhage: risk factors for progression in the early post-injury periodNeurosurgery58647656PubMedCrossRefGoogle Scholar
  3. Dutton, RP, McCunn, M, Hyder, M, D’Angelo, M, O’Connor, J, Hess, JR, Scalea, TM 2004Factor VIIa for correction of traumatic coagulopathyJ Trauma57709719PubMedGoogle Scholar
  4. Gerlach, R, Marquardt, G, Wissing, H, Scharrer, I, Raabe, A, Seifert, V 2002Application of recombinant activated factor VII during surgery for giant skull base hemangiopericytoma to achieve safe hemostasisJ Neurosurg96946948PubMedGoogle Scholar
  5. Hulka, F, Mullins, RJ, Frank, EH 1996Blunt brain injury activates the coagulation processArch Surg131923928PubMedGoogle Scholar
  6. Hoffman, M, Monroe, DM, Roberts, HR 1998Activated factor VII activates factors IX and X on the surface of activated platelets: thoughts on the mechanism of action of high-dose activated factor VIIBlood Coagul Fibrinolysis9S61S65PubMedGoogle Scholar
  7. Kluger, Y, Riou, B, Rossaint, R, Rizoli, SB, Boffard, KD, Choong, PI, Warren, B, Tillinger, M 2007Safety of rFVIIa in hemodynamically unstable polytrauma patients with traumatic brain injury: post hoc analysis of 30 patients from a prospective, randomized placebo-controlled, double-blind clinical trialCrit Care11R85PubMedCrossRefGoogle Scholar
  8. Lee, JH, Martin, NA, Alsina, G, McArthur, DL, Zaucha, K, Hovda, DA, Becker, DP 1997Hemodynamically significant cerebral vasospasm and outcome after head injury: a prospective studyJ Neurosurg87221233PubMedCrossRefGoogle Scholar
  9. Mayer, SA, Brun, NC, Begtrup, K, Broderick, J, Davis, S, Diringer, MN, Skolnick, BE, Steiner, T 2005Recombinant activated factor VII intracerebral hemorrhage trial investigators: recombinant activated factor VII for acute intracerebral hemorrhageN Engl J Med352777785PubMedCrossRefGoogle Scholar
  10. Morenski, JD, Tobias, JD, Jimenez, DF 2003Recombinant activated factor VII for cerebral injury-induced coagulopathy in pediatric patients. Report of three cases and review of the literatureJ Neurosurg98611616PubMedGoogle Scholar
  11. Oertel, M, Kelly, DF, McArthur, D, Boscardin, WJ, Glenn, TC, Lee, JH, Gravori, T, Obukhov, D, McBride, DQ, Martin, NA 2002Progressive hemorrhage after head trauma: predictors and consequences of the evolving injuryJ Neurosurg96109116PubMedGoogle Scholar
  12. Park, P, Fewel, ME, Garton, HJ, Thompson, BG, Hoff, JT 2003Recombinant activated factor VII for the rapid correction of coagulopathy in nonhemophilic neurosurgical patientsNeurosurgery533439PubMedCrossRefGoogle Scholar
  13. Scharrer, I 1999Recombinant factor VIIa for patients with inhibitors to factor VIII or IX or factor VII deficiencyHaemophilia5253259PubMedCrossRefGoogle Scholar
  14. Stein, SC, Young, GS, Talucci, RC, Greenbaum, BH, Ross, SE 1992Delayed brain injury after head trauma: significance of coagulopathyNeurosurgery30160165PubMedCrossRefGoogle Scholar
  15. Soustiel, JF, Shik, V 2004Posttraumatic basilar artery vasospasmSurg Neurol62201206PubMedCrossRefGoogle Scholar
  16. Wong, WY, Huang, WC, Miller, R, McGinty, K, Whisnant, JK 2000Clinical effect and recovery levels of recombinant FVIIa (NovoSeven) in the treatment of intracranial haemorrhage in severe neonatal FVII deficiencyHaemophilia65054PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  • M. Zaaroor
    • 1
  • J. F. Soustiel
    • 1
  • B. Brenner
    • 2
  • Y. Bar-Lavie
    • 3
  • U. Martinowitz
    • 4
  • L. Levi
    • 1
  1. 1.Department of Neurosurgery, Rambam Medical Centre and the B. Rappaport Faculty of MedicineTechnion-Israel Institute of TechnologyHaifaIsrael
  2. 2.Thrombosis and Haemostasis Unit, Rambam Medical Centre and the B. Rappaport Faculty of MedicineTechnion-Israel Institute of TechnologyHaifaIsrael
  3. 3.Department of Intensive CareRambam Medical CentreHaifaIsrael
  4. 4.The National Haemophilia CentreTel Hashomer Medical CentreTel HashomerIsrael

Personalised recommendations